Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Mai Ha Bui

Mai Ha Bui publishes mostly in Molecular Biology, Organic Chemistry and Hematology, on topics such as Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments and Ubiquitin and proteasome pathways.

OpenAlex
World rank
#1,259,651
of 7,710,434 ranked researchers
Rank in United States
#401,992
of 1,627,098
Works
107
Citations
1.9k
Citations per work
18.1
h-index
21
i10-index 24Top 30% in Molecular Biology
Mai Ha Bui

What does Mai Ha Bui research?

Mai Ha Bui's work is mostly in Biochemistry, Genetics and Molecular Biology (24%), Medicine (14%), Chemistry (9%).

Everything else: 51 works · 47.4% of their workLife Sciences: 26 works · 24.0% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 24.0% of their workMolecular Biology: 26 works · 24.0% of their workPhysical Sciences: 16 works · 14.7% of their workChemistry: 9 works · 8.5% of their workOrganic Chemistry: 9 works · 8.5% of their workPhysics and Astronomy: 7 works · 6.2% of their workNuclear and High Energy Physics: 3 works · 3.1% of their workRadiation: 3 works · 3.1% of their workHealth Sciences: 15 works · 13.9% of their workMedicine: 15 works · 13.9% of their workHematology: 9 works · 8.5% of their workOncology: 6 works · 5.4% of their workTHEIR WORKMai Ha Bui107works
Life Sciences24%Physical Sciences15%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else5147.4%
    1. Biochemistry, Genetics and Molecular Biology2624.0%
    1. Chemistry98.5%
    2. Physics and Astronomy76.2%
    1. Medicine1513.9%
  1. 1Molecular Biology24% of their works
  2. 2Organic Chemistry8% of their works
  3. 3Hematology8% of their works
  4. 4Oncology5% of their works
  5. 5Nuclear and High Energy Physics3% of their works
  6. 6Radiation3% of their works

Research topics

Which keywords describe Mai Ha Bui's research?

The keywords of their largest research topics: Proteasome Inhibitors, BET Bromodomains, Cancer Therapy, Diagnosis Criteria, International Myeloma Working Group, PROTACs, DNA and Proteasome.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Proteasome Inhibitors142 topics
  2. BET Bromodomains101 topic
  3. Cancer Therapy103 topics
  4. Diagnosis Criteria101 topic
  5. International Myeloma Working Group101 topic
  6. PROTACs101 topic
  7. DNA41 topic
  8. Proteasome41 topic
  9. Topoisomerases41 topic
  10. Ubiquitin41 topic
  11. Cell Cycle31 topic
  12. Cell Division31 topic
  13. HIF-131 topic
  14. Inorganic Scintillators31 topic
  15. Microtubules31 topic
  16. Scintillation Detectors31 topic
  17. Warburg Effect31 topic
  18. p5331 topic

Where does Mai Ha Bui work?

Mai Ha Bui's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Mai Ha Bui have?

OpenAlex counts 107 works and 1,933 citations for Mai Ha Bui, an h-index of 21, ranking #1,259,651 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mai Ha Bui. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.